Table 12.9a

Unadjusted Graft Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 3 Years, and 5 Years

		3 Months			1 Year			3 Years			5 Years
		N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.	N	%	Std. Err.
Total	All	1,975	88.1%	0.7%	1,975	77.0%	1.0%	1,699	57.7%	1.2%	1,696	43.6%	1.2%
Primary Diagnosis	Emphysema/COPD	872	91.1%	1.0%	872	82.2%	1.3%	706	63.4%	1.8%	633	43.8%	2.0%
	Cystic Fibrosis	301	91.3%	1.6%	301	81.7%	2.3%	268	63.9%	3.0%	286	47.0%	3.0%
	Idiopathic Pulmonary Fibrosis	298	82.4%	2.2%	298	68.0%	2.7%	277	43.0%	3.0%	260	41.2%	3.1%
	Alpha-1-Antitrypsin Deficiency	150	86.4%	2.8%	150	69.3%	3.8%	130	55.9%	4.4%	155	48.6%	4.1%
	Primary Pulmonary Hypertension	74	81.0%	4.6%	74	69.7%	5.4%	77	59.0%	5.7%	87	30.8%	5.0%
	Retransplant/Graft Failure	46	69.6%	6.8%	46	51.5%	7.5%	41	28.7%	7.1%	58	35.8%	6.5%
	Congenital Disease	22	90.9%	6.1%	22	77.3%	8.9%	30	53.1%	9.1%	32	33.3%	9.0%
	Other	212	86.7%	2.3%	212	74.7%	3.0%	168	56.6%	3.9%	185	47.4%	3.7%
	Unknown	0	-	-	0	-	-	2	100.0%	0.0%	0	-	-

Source: OPTN/SRTR Data as of August 1, 2003.

(+) = Values not determined due to insufficient follow-up.

(-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during 2000-2001 for 3 month and 1 year; 1998-1999 for 3 year; and 1996-1997 for 5 year survival.

Graft survival follows individual transplants until graft failure.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.